Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
about
Reconstitution and Functional Analysis of a Full-Length Hepatitis C Virus NS5B Polymerase on a Supported Lipid Bilayer.Prevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapyBroad-spectrum agents for flaviviral infections: dengue, Zika and beyondNew Therapies for Hepatitis C Virus Infection.New prospects for the treatment and prevention of hepatitis C in children.Anti-norovirus therapeutics: a patent review (2010-2015).Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents.Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV.NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B.GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses.Treatment of chronic genotype-3 hepatitis C virus infection using direct-acting antiviral agents: An Indian experience.Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.Guanine α-carboxy nucleoside phosphonate (G-α-CNP) shows a different inhibitory kinetic profile against the DNA polymerases of human immunodeficiency virus (HIV) and herpes viruses.Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.Pharmacokinetics, efficacy prediction indexes, and residue depletion of ribavirin in Atlantic salmon's (Salmo salar) muscle after oral administration in feed.Phosphocholine conjugation: an unexpected in vivo conjugation pathway associated with hepatitis c ns5b inhibitors featuring a bicyclo[1.1.1]pentane.Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure.Structural and Functional Basis of the Fidelity of Nucleotide Selection by Flavivirus RNA-Dependent RNA Polymerases.Structure and function of Zika virus NS5 protein: perspectives for drug design.RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution.Emergency Services of Viral RNAs: Repair and Remodeling.Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
P2860
Q27469069-F820E529-6911-45F3-82C7-95D00A2FFA8FQ28076466-92F5889D-E7E2-429B-B003-34C5DA8CF1A1Q29994527-6B73477B-DDE9-46A4-8705-9DF6C0BFF167Q33560181-737DD08B-B201-4768-A4B8-9F1F283EFCF9Q36608054-D2BEBEB3-5D28-4248-9AB5-5CF8D6FA1B41Q37101808-C957B1C5-52DC-4224-B719-D8C6137D0B53Q38992902-7480FD97-DEF5-4594-8A9A-6EF3F41C886CQ39307349-D7601F83-C1D3-4657-B8C6-C6EC8AB288B9Q40040199-0961CE49-B07B-404B-8ACD-9B2036E265DBQ40066603-32026F5D-CA37-4FC8-83EE-07FB280FBBD3Q40143151-9A8A3164-5810-4BC4-B0C5-15AFB8DC911CQ40144736-857FBCBA-EFC0-4BD3-8582-A04E1FFD2B7CQ40251943-4ABC5ECF-2E23-469E-9DA6-0687A58ECBBBQ40368500-E0E057E3-E980-49AB-9F38-F6F12159EFE5Q40761586-41709DD9-D994-468D-B229-3D9C9CD9C177Q40862619-AE71D7C1-8E85-4DCE-A8A9-83866A5B2910Q42334232-F77D2740-541D-4EFF-9922-484C3C8F38B9Q47547559-27BE43B4-8760-4920-8203-E04F3056186BQ48504896-2275E3D6-0246-403B-A85F-87ECA1D5283AQ50034148-AB9D00F4-9F90-4E65-B5D7-BF07BC07E2FBQ52655516-9FBA9359-E057-4FC2-9DD2-87C8BF1A1205Q53704198-FFF4E5F9-192F-4C7F-9131-7644D0FE5756
P2860
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
@ast
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
@en
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
@nl
type
label
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
@ast
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
@en
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
@nl
prefLabel
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
@ast
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
@en
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
@nl
P2860
P50
P921
P3181
P356
P1433
P1476
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
@en
P2860
P304
P3181
P356
10.3390/V7102868
P407
P577
2015-09-29T00:00:00Z
2015-10-01T00:00:00Z